Nomura SPARX
VC Fund
Tokyo, Japan
Nomura SPARX is a VC fund in Tokyo focused on Medical and E-Commerce. Nomura SPARX provides funds and assistance to unlisted companies. It offers investment management and financial consultation to help businesses grow. Nomura SPARX was founded in 2021 and is based in Tokyo, Japan.
- Total investments:
- 10
- Last investment:
- Lead investor:
- 20%
Last updated:
For AI agents: llms.txt
Industries Nomura SPARX invests in
Stages Nomura SPARX invests in
Countries Nomura SPARX invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
4 more contacts available
Investment Focus
Industry
- Medical 2 (20%)
- E-Commerce 2 (20%)
- Health Care 2 (20%)
- Biotechnology 2 (20%)
- Health Diagnostics 2 (20%)
Stage
- Series B 4 (40%)
- Series A 2 (20%)
- Series C 2 (20%)
- Seed 1 (10%)
- Series D 1 (10%)
Country
- Japan 7 (70%)
- Singapore 1 (10%)
- United States 1 (10%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Ichitaro Akita
Head of Investment Management (CIO)
|
Head of Investment Management (CIO) | Total investments: 4 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
SONIRE Therapeutics
|
SONIRE Therapeutics is a clinical-stage medical device company. It is a U.S. subsidiary of SONIRE Therapeutics Co., Ltd.. | $18M / Series A / Apr 15, 2026 | |
|
|
SONIRE Therapeutics Inc. (SONIRE) is working on a next-generation high-intensity focused ultrasound (HIFU) therapy system that will employ acoustic engineering (ultrasound) technologies developed through cutting-edge academic research. SONIRE has been working on a next-generation high-intensity focused ultrasound (HIFU) treatment system as a noveltherapeutic modality with the goal of giving cancer patients and their families a new future. | $18M / Series A / Apr 15, 2026 | |
|
|
Linqmed is a pharmaceutical company that specializes in the research and development of radiopharmaceuticals for cancer treatment. | $15.9M / Series B / Apr 09, 2025 | |
|
|
GiftMall is an e-commerce platform specializing in gift experiences that change society. GiftMall creates irreplaceable moments by solving problems in the gift industry and providing highly innovative services. GiftMall promotes data-driven innovation through big data, AI technology, and collaborative creativity. | $26.5M / Series B / Oct 22, 2024 | |
|
|
Openrec is a live-streaming platform that focuses on game commentary and online event business. | $15.4M / Seed / May 08, 2024 | |
|
|
MOON-X serves as a launch pad for brands through co-creation with communities and manufacturing partners. MOON-X's brand categories include baby and maternity, leather accessories, business goods, liquor, and men's and women's skincare. | $23.8M / Series C / Jan 30, 2024 | |
|
|
ThinkCyte provides single-cell analysis for research, diagnostics, and therapeutics with an integrated multidisciplinary approach. | $22.4M / Series C / Nov 28, 2023 | |
|
|
MOON-X serves as a launch pad for brands through co-creation with communities and manufacturing partners. MOON-X's brand categories include baby and maternity, leather accessories, business goods, liquor, and men's and women's skincare. | $25.3M / Series B / Jul 28, 2022 | |
|
|
AnyMind Group has created one of the first end-to-end brand enablement platforms, developing and providing inter-connected software and offerings to enable businesses and individuals - from brand building, manufacturing and e-commerce, to marketing, logistics and global expansion. The company is on a mission to make every business borderless byremoving borders between businesses and customers, online and offline, and between industries, data silos, geographical boundaries and more. AnyMind Group was founded in Singapore in April 2016, and has since expanded into 13 markets and 17 offices including Thailand, Indonesia, Vietnam, Cambodia, Malaysia, the Philippines, Hong Kong, Taiwan, Mainland China, Japan, India and the United Arab Emirates. For more information, visit us at https://anymindgroup.com | $28.9M / Series D / Jul 18, 2022 | |
|
|
Synspective provides SAR data and remote monitoring services to government agencies. Its satellite data technology utilizes and integrates data from satellite constellations, big data, and machine learning. It provides various satellite services, including remote sensing and satellite imagery using small-sized SAR satellites that can measure humanactivity over a wide area on earth, regardless of time or weather. | $96.3M / Series B / Mar 28, 2022 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Nomura SPARX invest in?
Nomura SPARX invests primarily in Medical, E-Commerce and Health Care startups, most often at Series B and Series A stage. Most of the 10 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Nomura SPARX?
For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Nomura SPARX?
The team at Nomura SPARX includes Ichitaro Akita (Head of Investment Management (CIO)). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!